| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w9229 |
| 来源ID | Working Paper 9229 |
| \"Napsterizing\" Pharmaceuticals: Access, Innovation, and Consumer Welfare | |
| James W. Hughes; Michael J. Moore; Edward A. Snyder | |
| 发表日期 | 2002-09-25 |
| 出版年 | 2002 |
| 语种 | 英语 |
| 摘要 | We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without compensation to the patent holders. The question of whether this policy maximizes consumer welfare cannot be resolved on an a priori basis due to an obvious tradeoff: While accelerating generic entry will yield substantial gains in consumer surplus associated with greater access to the current stock of pharmaceuticals, future consumers will be harmed by reducing the flow of new pharmaceuticals to the market. Our estimates of the consumer surpluses at stake are based on the stylized facts concerning how generic entry has affected prices, outputs, and market shares. We find that providing greater access to the current stock of prescription drugs yields large benefits to existing consumers. However, realizing those benefits has a substantially greater cost in terms of lost consumer benefits from reductions in the flow of new drugs. Specifically, the model yields the result that for every dollar in consumer benefit realized from providing greater access to the current stock, future consumers would be harmed at a rate of three dollars in present value terms from reduced future innovation. We obtain this result even accounting for the stylized fact that after generic entry branded drugs continue to earn significant price premia over generic products and hence recognizing that Napsterizing does not completely eliminate the incentives to innovate. |
| 主题 | Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w9229 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/566842 |
| 推荐引用方式 GB/T 7714 | James W. Hughes,Michael J. Moore,Edward A. Snyder. \"Napsterizing\" Pharmaceuticals: Access, Innovation, and Consumer Welfare. 2002. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w9229.pdf（1239KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
